CMI Communications

16/04/2026

starts TOMORROW! And we are so excited to be here. Join the CMI Comms' editorial board in sessions they helped co-organise, which you can see here: https://www.cmi-comms.org/asocmi

16/04/2026

📣 New drops Mon, 20 April!

Thomas Tängdén, Erin McCreary, PharmD & Angela Huttner host Amy Legg & Rekha Pai for the first part in our new series on all things PK/PD! This episode introduces the topic broadly, defines essential concepts & discusses use cases in daily practice.🎙️

14/04/2026

📣Friedland on -directed therapies & :

The study of physiology was central in the 20th century but now is something of a backwater, with attention focused on genetics & immunology to generate therapies. This must change..it impedes the development of effective HDTs.

https://ow.ly/1NuU50YIFYo

14/04/2026

📣 In vitro studies point to synergy between ertapenem and both cefazolin and nafcillin.

In this cohort of >50 patients with receiving dual therapy, mortality & valve-replacement rates were lower than expected.

https://ow.ly/r3gH50YIF86

05/04/2026

🎙️ Just published Communicable E50: Quarterly catch-up

Hosted by Emily McDonald, Thomas Tängdén and Navaneeth Narayanan

Listen on : https://share.transistor.fm/s/10d045b8

02/04/2026

📣 New drops Mon, 06 April!

Emily McDonald, Thomas Tängdén & Nav Narayanan host the first of this new series, 'Quarterly catch-up', in which they summarize important articles in CM/ID published in the last 3 months, and elaborate their impact on clinical practice. Tune in!🎙️

22/03/2026

🎙️ Just published Communicable E49: Outbreaks & how to handle them

Hosted by Angela Huttner & Marc Bonten w/ invited guests Martin Grobusch (Netherlands) and Pikka Jokelainen (Denmark) of the ESCMID Emerging Infections Subcommittee

Listen on : https://share.transistor.fm/s/28f44d60

20/03/2026

📣 Fever, dyspnea & stridor in an immunosuppressed patient with high but no lung lesions...

New comprehensive review by Wu et al. on thyroid compiling all cases known to date.

https://www.cmi-comms.org/article/S2950-5909(26)00006-5/

19/03/2026

📣 New drops Monday, 23 March! Angela Huttner & Marc Bonten host Martin Grobusch & Pikka Jokelainen of the ESCMID Emerging Infections Subcommittee to discuss how to deal with outbreaks, what One Health really means, and the launch of the esteemed Epi Alert. 🎙️

19/03/2026

📣 is increasing everywhere: spreading to new geographic regions and on the rise in endemic regions.

New concise clinical review by experts Lim and Chua, who share their expertise & experience.

https://ow.ly/jSfo50Ywaj3

Dengue fever is a significant public health concern in tropical and subtropical regions. Its global burden has risen rapidly in recent years, with cli…

08/03/2026

🎙️ Just published Communicable E48: International Women's Day - are infections & AMR really different in women?
Hosted by Erin McCreary & Annie Joseph w/ invited guests Esmita Charani (South Africa) & Annette Westgeest (Netherlands)

Listen on : https://share.transistor.fm/s/cc75e63e

06/03/2026

📣 New CLARITY articles on the GAMECHANGER trial
The second article by Erin McCreary & Ahmad Mourad examines -inferiority trials more generally, providing a concise guide to their indications, strengths and weaknesses

CMI CommunicationsVolume 3, Issue 1, March 2026, 105175CommentaryReframing success: lessons on noninferiority trials from GAME CHANGERAuthor links open overlay panelAhmad Mourad 1 2, Erin K. McCreary 3Show moreAdd to MendeleyShareCitehttps://doi.org/10.1016/j.cmicom.2026.105175Get rights and content...